MSB 5.24% $1.11 mesoblast limited

Yes Execution of Ryoncil Approval and commercial phase execution...

  1. 1,962 Posts.
    lightbulb Created with Sketch. 696
    Yes Execution of Ryoncil Approval and commercial phase execution leads to:

    - US Ryoncil aGVHD use

    - US Ryoncil Label Extension use - Adults etc

    - US Ryoncil Off Label Use - ARDS, Chrons, IBD, MIS-C etc etc and etc…keep going.

    - Parternship(s) for approval and distribution in Rest of World Countries. Japan already on board. Dozens of countries/regions to follow.

    - Likely RoW use will accelerate the use of Ryoncil in even more inflammatory disease off label situation’s. That will take on a life of its own globally.

    = Savings lots of lives and lots of revenues Worldwide

    That is just Ryoncil …then we have on Rexy on the burst also …same, same and same commercial execution model.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.